All ABPI members and any pharmaceutical company that follows ABPI's Code of Practice for the Pharmaceutical Industry are required to disclose certain transfers of value - payments and other benefits in kind made to healthcare organisations that they work with.
The disclosure of certain payments and benefits in kind is about bringing further transparency to the relationship between the pharmaceutical industry and the healthcare professionals and organisations it works with. It is a relationship that is critical to the future of medical innovation and patient care and as such, should meet the high expectations of patient and wider stakeholders.
In its recently published guidance Managing conflicts of interest in the NHS, NHS England recommends that NHS organisations should 'seek to ensure that staff who are subject to wider transparency initiatives such as the ABPI Disclosure UK scheme are aware of and comply with them'.
Industry only collaborates with a small proportion of the UK healthcare professional workforce. If you search Disclosure UK and do not find the doctor, nurse, pharmacist, hospital specialist or other healthcare professional that is treating you, then the most likely answer is that they have not worked with a pharmaceutical company.
However, it is possible that they have exercised their rights under data protection legislation and not given their permission for us to publish details of their interactions with industry.
If you would like to know if your healthcare professional has collaborated with industry we suggest that you ask them.